Literature DB >> 24838744

Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010.

Andrea Sanchini1, Ilka McCormick Smith, Ludwig Sedlacek, Roman Schwarz, Kathrin Tintelnot, Volker Rickerts.   

Abstract

Cryptococcosis is a fungal infection mostly caused by Cryptococcus neoformans. We identified agents of cryptococcosis diagnosed in Germany from 2004 to 2010. We used multi-locus sequence typing (MLST) to understand the molecular epidemiology of cryptococcosis. Sero- and mating types of individual patient isolates were determined by PCR. MLST was performed using the seven-locus scheme. Allele and nucleotide diversity was calculated for each locus of C. neoformans var. grubii and C. neoformans var. neoformans. Phylogenetic relations were assessed by dendrograms. Clinical data were compared between infections caused by the two variants. We studied 101 isolates. Eight were identified as hybrids (8%). All non-hybrids were of the α mating type. Among 78 C. neoformans var. grubii (77%), 16 sequence types (STs) were identified including three novel STs. They clustered in four groups, previously isolated in Asia, Europe or worldwide. Among 15 C. neoformans var. neoformans (15%), 10 STs were identified, without clustering. These isolates showed higher allele, and nucleotide diversity compared with C. neoformans var. grubii. C. neoformans var. neoformans was more likely to cause soft-tissue infections (3/9, 33 vs. 1/63, 2%, p = 0.005) and to affect non-AIDS patients (7/14, 50 vs. 15/76, 20%, p = 0.036). C. neoformans var. grubii is the predominant agent of cryptococcosis in Germany. MLST suggests that a part of these cases are acquired abroad by immigrants or tourists. C. neoformans var. neoformans isolates represent a greater genetic diversity and are associated with more variable clinical presentations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838744     DOI: 10.1007/s00430-014-0341-6

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  37 in total

1.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

Review 2.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

Review 3.  Cryptococcosis: update and emergence of Cryptococcus gattii.

Authors:  Sally J Lester; Richard Malik; Karen H Bartlett; Colleen G Duncan
Journal:  Vet Clin Pathol       Date:  2011-01-18       Impact factor: 1.180

4.  Primary cutaneous cryptococcosis: a distinct clinical entity.

Authors:  Ségolène Neuville; Françoise Dromer; Odile Morin; Bertrand Dupont; Olivier Ronin; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2003-01-17       Impact factor: 9.079

Review 5.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

6.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

Review 7.  Virulence in Cryptococcus species.

Authors:  Hansong Ma; Robin C May
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

8.  Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis.

Authors:  Darin L Wiesner; Oleksandr Moskalenko; Jennifer M Corcoran; Tami McDonald; Melissa A Rolfes; David B Meya; Henry Kajumbula; Andrew Kambugu; Paul R Bohjanen; Joseph F Knight; David R Boulware; Kirsten Nielsen
Journal:  MBio       Date:  2012-09-25       Impact factor: 7.867

9.  Population genetic analyses reveal the African origin and strain variation of Cryptococcus neoformans var. grubii.

Authors:  Anastasia P Litvintseva; Thomas G Mitchell
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

10.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more
  16 in total

1.  Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.

Authors:  Massimo Cogliati; Roberta D'Amicis; Alberto Zani; Maria Teresa Montagna; Giuseppina Caggiano; Osvalda De Giglio; Stella Balbino; Antonella De Donno; Francesca Serio; Serdar Susever; Cagri Ergin; Aristea Velegraki; Mohamed S Ellabib; Simona Nardoni; Cristina Macci; Salvatore Oliveri; Laura Trovato; Ludovico Dipineto; Volker Rickerts; Ilka McCormick-Smith; Sevim Akcaglar; Okan Tore; Emilija Mlinaric-Missoni; Sebastien Bertout; Michele Mallié; Maria da Luz Martins; Ana C F Vencà; Maria L Vieira; Ana C Sampaio; Cheila Pereira; Giuseppe Criseo; Orazio Romeo; Stéphane Ranque; Mohammed H Y Al-Yasiri; Meltem Kaya; Nilgun Cerikcioglu; Anna Marchese; Luigi Vezzulli; Macit Ilkit; Marie Desnos-Ollivier; Vincenzo Pasquale; Maya Korem; Itzhack Polacheck; Antonio Scopa; Wieland Meyer; Kennio Ferreira-Paim; Ferry Hagen; Bart Theelen; Teun Boekhout; Shawn R Lockhart; Kathrin Tintelnot; Anna Maria Tortorano; Françoise Dromer; Ashok Varma; Kyung J Kwon-Chung; Joäo Inácio; Beatriz Alonso; Maria F Colom
Journal:  FEMS Yeast Res       Date:  2016-05-05       Impact factor: 2.796

2.  Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population.

Authors:  Massimo Cogliati; Alberto Zani; Volker Rickerts; Ilka McCormick; Marie Desnos-Ollivier; Aristea Velegraki; Patricia Escandon; Tomoe Ichikawa; Reiko Ikeda; Anne-Lise Bienvenu; Kathrin Tintelnot; Okan Tore; Sevim Akcaglar; Shawn Lockhart; Anna Maria Tortorano; Ashok Varma
Journal:  Fungal Genet Biol       Date:  2016-01-06       Impact factor: 3.495

3.  Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species.

Authors:  Anne Bernhardt; Wieland Meyer; Volker Rickerts; Toni Aebischer; Kathrin Tintelnot
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  An analysis of the population of Cryptococcus neoformans strains isolated from animals in Poland, in the years 2015-2019.

Authors:  Magdalena Florek; Urszula Nawrot; Agnieszka Korzeniowska-Kowal; Katarzyna Włodarczyk; Anna Wzorek; Anna Woźniak-Biel; Magdalena Brzozowska; Józef Galli; Anna Bogucka; Jarosław Król
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

Review 5.  Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and Strategies.

Authors:  Onyema Ogbuagu; Merceditas Villanueva
Journal:  Infect Dis Rep       Date:  2014-11-19

6.  MLST-Based Population Genetic Analysis in a Global Context Reveals Clonality amongst Cryptococcus neoformans var. grubii VNI Isolates from HIV Patients in Southeastern Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Fernanda M Fonseca; Thatiana B Ferreira; Delio J Mora; Juliana Andrade-Silva; Aziza Khan; Aiken Dao; Eduardo C Reis; Margarete T G Almeida; Andre Maltos; Virmondes R Junior; Luciana Trilles; Volker Rickerts; Ariya Chindamporn; Jane E Sykes; Massimo Cogliati; Kirsten Nielsen; Teun Boekhout; Matthew Fisher; June Kwon-Chung; David M Engelthaler; Marcia Lazéra; Wieland Meyer; Mario L Silva-Vergara
Journal:  PLoS Negl Trop Dis       Date:  2017-01-18

7.  Multilocus Sequence Typing Reveals both Shared and Unique Genotypes of Cryptococcus neoformans in Jiangxi Province, China.

Authors:  Yan-Hui Chen; Feng Yu; Ze-Yuan Bian; Jian-Ming Hong; Nan Zhang; Qiao-Shi Zhong; Ya-Ping Hang; Jianping Xu; Long-Hua Hu
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

8.  Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.

Authors:  Leonardo Euripedes Andrade-Silva; Kennio Ferreira-Paim; Thatiana Bragine Ferreira; Anderson Vilas-Boas; Delio José Mora; Verônica Morais Manzato; Fernanda Machado Fonseca; Kelli Buosi; Juliana Andrade-Silva; Bruno da Silva Prudente; Natalia Evelyn Araujo; Helioswilton Sales-Campos; Marcus Vinicius da Silva; Virmondes Rodrigues Júnior; Wieland Meyer; Mario Léon Silva-Vergara
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

9.  MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil.

Authors:  Diego Fernando Silva Rocha; Katia Santana Cruz; Carla Silvana da Silva Santos; Lizandra Stephanny Fernandes Menescal; João Ricardo da Silva Neto; Silviane Bezerra Pinheiro; Lucyane Mendes Silva; Luciana Trilles; João Vicente Braga de Souza
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

10.  Multilocus sequence typing of Cryptococcus neoformans var. grubii from Laos in a regional and global context.

Authors:  Lam Tuan Thanh; Trieu Hai Phan; Sayaphet Rattanavong; Trinh Mai Nguyen; Anh Van Duong; Cherrelle Dacon; Thu Nha Hoang; Lan Phu Huong Nguyen; Chau Thi Hong Tran; Viengmon Davong; Chau Van Vinh Nguyen; Guy E Thwaites; Maciej F Boni; David Dance; Philip M Ashton; Jeremy N Day
Journal:  Med Mycol       Date:  2018-10-19       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.